Pricing Log in Create free account

Eocene Ltd. (EOCN) vs GRI Bio, Inc. (GRI)

Eocene Ltd. and GRI Bio, Inc. are both Biotechnology companies. Eocene Ltd. and GRI Bio, Inc. are of similar size ($3.2M and $3.1M). Eocene Ltd. has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. Across the 10 metrics below, Eocene Ltd. leads on 5 and GRI Bio, Inc. on 5.

Valuation

Metric EOCN GRI Biotechnology median
P/E n/m 0.02 8.50
P/S 1.33 n/m 9.71
P/B 0.21 0.24 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.61 0.86 0.64
EV/Sales (3.00) n/m 9.21
Earnings yield (532.63%) 5,408.03% (33.15%)
Free cash flow yield (314.99%) (418.56%) (25.50%)

Profitability

Metric EOCN GRI Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (68.21%) (142.02%) (56.36%)
Return on assets (55.03%) (113.27%) (48.04%)
Return on invested capital (163.19%) 0.00% 0.00%

Growth

Metric EOCN GRI Biotechnology median
Revenue growth (TTM) 87.83% — 6.02%
EPS growth (last fiscal year) 70.42% 92.12% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EOCN GRI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.16 10.30 4.72
Net debt to EBITDA 1.31 0.69 0.96

Dividend

Metric EOCN GRI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EOCN GRI Biotechnology median
Market cap 3.18m 3.06m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack